<VariationArchive VariationID="12100" VariationName="NM_000196.4(HSD11B2):c.343_348del (p.Glu115_Leu116del)" VariationType="Deletion" Accession="VCV000012100" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-05-08" DateCreated="2016-10-23" MostRecentSubmission="2019-03-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="27139" VariationID="12100">
      <GeneList>
        <Gene Symbol="HSD11B2" FullName="hydroxysteroid 11-beta dehydrogenase 2" GeneID="3291" HGNC_ID="HGNC:5209" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="67429801" stop="67437553" display_start="67429801" display_stop="67437553" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="67465035" stop="67471455" display_start="67465035" display_stop="67471455" Strand="+" />
          </Location>
          <OMIM>614232</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000196.4(HSD11B2):c.343_348del (p.Glu115_Leu116del)</Name>
      <CanonicalSPDI>NC_000016.10:67435701:TTGGAGTTG:TTG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="67435702" stop="67435707" display_start="67435702" display_stop="67435707" variantLength="6" positionVCF="67435701" referenceAlleleVCF="ATTGGAG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="67469605" stop="67469610" display_start="67469605" display_stop="67469610" variantLength="6" positionVCF="67469604" referenceAlleleVCF="ATTGGAG" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.67435705_67435710del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.67435705_67435710del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.67469608_67469613del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.67469608_67469613del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016549.1" sequenceAccession="NG_016549" sequenceVersion="1" change="g.9573_9578del">
            <Expression>NG_016549.1:g.9573_9578del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000196.4" sequenceAccession="NM_000196" sequenceVersion="4" change="c.343_348del" MANESelect="true">
            <Expression>NM_000196.4:c.343_348del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000187.3" sequenceAccession="NP_000187" sequenceVersion="3" change="p.Glu115_Leu116del">
            <Expression>NP_000187.3:p.Glu115_Leu116del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA212939" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="614232.0008" DB="OMIM" />
        <XRef Type="rs" ID="794726669" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000196.4(HSD11B2):c.343_348del (p.Glu115_Leu116del) AND Apparent mineralocorticoid excess" Accession="RCV000761442" Version="2">
        <ClassifiedConditionList TraitSetID="3273">
          <ClassifiedCondition DB="MedGen" ID="C0342488">Apparent mineralocorticoid excess</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2017-12-30" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000196.4(HSD11B2):c.343_348del (p.Glu115_Leu116del) AND Apparent mineralocorticoid excess, mild" Accession="RCV000012882" Version="5">
        <ClassifiedConditionList TraitSetID="3275">
          <ClassifiedCondition DB="MedGen" ID="C4017360">Apparent mineralocorticoid excess, mild</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-03-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-12-30" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2016-10-23" MostRecentSubmission="2019-03-24">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">11238516</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15134813</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Uncertain significance(1)</Comment>
        <DescriptionHistory Dated="2019-03-22">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="3273" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6464" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Apparent mineralocorticoid excess</ElementValue>
                <XRef ID="Apparent+Mineralocorticoid+Excess/560" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009025" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cortisol 11-beta-ketoreductase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AME 1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">AME1</ElementValue>
                <XRef Type="MIM" ID="218030" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">AME</ElementValue>
                <XRef Type="MIM" ID="218030" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="433" />
                <XRef ID="433" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Apparent mineralocorticoid excess (AME) is an autosomal recessive form of low-renin hypertension associated with low aldosterone, metabolic alkalosis, hypernatremia, and hypokalemia. The disorder is due to a congenital defect in 11-beta-hydroxysteroid dehydrogenase type II (HSD11B2) activity, resulting in decreased conversion of biologically active cortisol to inactive cortisone; this defect allows cortisol to act as a ligand for the mineralocorticoid receptor, resulting in sodium retention and volume expansion. There is a favorable therapeutic response to spironolactone (review by Ferrari, 2010).</Attribute>
                <XRef Type="MIM" ID="218030" DB="OMIM" />
              </AttributeSet>
              <XRef ID="320" DB="Orphanet" />
              <XRef ID="C0342488" DB="MedGen" />
              <XRef ID="MONDO:0009025" DB="MONDO" />
              <XRef Type="MIM" ID="218030" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3275" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10949" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Apparent mineralocorticoid excess, mild</ElementValue>
              </Name>
              <XRef ID="C4017360" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="33123" SubmissionDate="2016-10-21" DateLastUpdated="2016-10-23" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="614232.0008_APPARENT MINERALOCORTICOID EXCESS, MILD" title="HSD11B2, 6-BP DEL, LEU114/GLU115_APPARENT MINERALOCORTICOID EXCESS, MILD" />
        <ClinVarAccession Accession="SCV000033123" DateUpdated="2016-10-23" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Odermatt et al. (2001) reported 2 sibs, aged 1 and 2 years, who were diagnosed with hypokalemic hypertension and low plasma aldosterone and renin levels, indicating mineralocorticoid hypertension (AME; 218030). Analysis of urinary steroid metabolites showed a markedly impaired metabolism of cortisol and nearly absent urinary free cortisone. Although phenotypically normal, the heterozygous parents showed a disturbed cortisol metabolism. Genetic analysis of the HSD11B2 gene from the AME patients revealed the homozygous deletion of 6 nucleotides in exon 2, with the resultant loss of amino acids leu114 and glu115, representing the first alteration found in the cofactor-binding domain. The deletion mutant, expressed in HEK293 cells, showed an approximately 20-fold lower maximum velocity but increased apparent affinity for cortisol and corticosterone. Functional analysis of wildtype and mutant proteins indicated that a disturbed conformation of the cofactor-binding domain, but not the missing negative charge of glu115, led to the observed decreased activity of the deletion mutant. The authors concluded that their findings provided evidence for a role of glu115 in determining cofactor-binding specificity of HSD11B2 and emphasized the importance of structure-function analysis to elucidate the molecular mechanism of apparent mineralocorticoid excess.</Attribute>
              <Citation>
                <ID Source="PubMed">11238516</ID>
              </Citation>
              <XRef DB="OMIM" ID="218030" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HSD11B2" />
          </GeneList>
          <Name>HSD11B2, 6-BP DEL, LEU114/GLU115</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">6-BP DEL, LEU114/GLU115</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="614232.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">APPARENT MINERALOCORTICOID EXCESS, MILD</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1747324" SubmissionDate="2018-10-25" DateLastUpdated="2019-03-24" DateCreated="2019-03-24">
        <ClinVarSubmissionID localKey="NM_000196.3:c.343_348del|OMIM:218030" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000891524" DateUpdated="2019-03-24" DateCreated="2019-03-24" Type="SCV" Version="1" SubmitterName="Department Of Genetics, Sultan Qaboos University Hospital, Sultan Qaboos University" OrgID="506653" OrganizationCategory="laboratory" OrgAbbreviation="SQUH-Genetics" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-12-30">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15134813</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <GeographicOrigin>Middle East</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HSD11B2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000196.3:c.343_348del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="218030" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4684823</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1747324" TraitType="Disease" MappingType="XRef" MappingValue="218030" MappingRef="OMIM">
        <MedGen CUI="C0342488" Name="Apparent mineralocorticoid excess" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="33123" TraitType="Disease" MappingType="Name" MappingValue="APPARENT MINERALOCORTICOID EXCESS, MILD" MappingRef="Preferred">
        <MedGen CUI="C4017360" Name="Apparent mineralocorticoid excess, mild" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

